GlassScriptPrepare for your visit
Khadija Hamid
Family Medicine · Yukon, OK · NPI 1538749122
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$753.21
in general payments reported to CMS, 2019-2025 · $666 in 2025
The $666 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $156.90
- Sanofi-Aventis U.S. LLC $146.22
- Pfizer INC. $97.90
- Lilly USA, LLC $94.83
- Astrazeneca Pharmaceuticals LP $84.31
- Astellas Pharma US INC $32.03
Drugs and devices associated with these payments
Tzield Qulipta Ubrelvy Zepbound Abrysvo Comirnaty Prevnar 20 Mounjaro Airsupra Zavzpret Nurtec Odt Veozah
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Khadija Hamid listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11423576/khadija-hamid